Very early MRI responses to therapy as a predictor of later radiographic progression in early rheumatoid arthritis
Article in Arthritis Research & Therapy (October 2019)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Tofacitinib in Rheumatoid Arthritis: Lack of Early Change in Disease Activity and the Probability of Achieving Low Disease Activity at Month 6
Article in Arthritis Care & Research (December 2018)
Iguratimod, a synthetic disease modifying anti-rheumatic drug inhibiting the activation of NF-κB and production of RANKL: Its efficacy, radiographic changes, safety and predictors over two years’ treatment for Japanese rheumatoid arthritis patients
Article in Modern Rheumatology (July 2018)